SIK2 and acute lymphoblastic leukemia: The SIK1 activity, but not SIK2/3 activity, is predicted higher in patients with ETP-ALL compared with other patients with T-ALL who have relatively higher predicted SIK2 and SIK3 kinase activities (Supplemental Figure 9, D–F).